Development code · Small Molecule
CTN
CTN is a development code for Centanafadine, developed by Otsuka Pharmaceutical Co., Ltd..
- Status
- Filed (NDA) for Attention-deficit/hyperactivity disorder
- Mechanism
- NET Reuptake inhibitor
- Developer
- Otsuka Pharmaceutical Co., Ltd.
Programs
- Centanafadine for Attention-deficit/hyperactivity disorderFiled (NDA)Active
Also known as
- Centanafadine
- EB-1020
- 924012-43-1
- (1R,5S)-1-naphthalen-2-yl-3-azabicyclo[3.1.0]hexane